...
机译:围手术期抗otherapy应该取代预防性抗生素,以术前胆道引流前面的胰腺癌切除术。
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
Department of Biology of Cardiovascular Diseases INSERM UMR 1034University of BordeauxPessac France;
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
Department of Biology of Cardiovascular Diseases INSERM UMR 1034University of BordeauxPessac France;
Department of Digestive And Endocrinology Surgery Centre for Digestive System Diseases;
complications; morbidity; pancreatic fistula; pancreaticoduodenectomy; perioperative antibiotherapy; preoperative biliary drainage;
机译:围手术期抗otherapy应该取代预防性抗生素,以术前胆道引流前面的胰腺癌切除术。
机译:术前胆道引流桥是接受胰腺癌患者的有用管理
机译:术前胆管引流患者胰十二指肠切除术后的结果。
机译:评估和改善围手术期:评估和重新设计术前患者评估
机译:接受胰十二指肠切除术的患者与院内出血并发症相关的危险因素。
机译:在胰腺癌术前术前胆道引流的患者的重大发病率降低了胆红素的率降低
机译:术后复苏术后复苏,发病率和死亡率的选择性术前胆道引流效果可忽略不计,胰腺炎症